ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc. (ARYX) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 46 transactions totaling $36.4M, demonstrating a bullish sentiment with $17.2M in net insider flow. The most recent transaction on Mar 10, 2011 involved a sale of 4,469,274 shares valued at $312.8K.
ARYX Insider Activity Summary
Who Is Buying ARYX Stock?
No significant insider buying has been recorded for ARYX in the recent period.
Who Is Selling ARYX Stock?
No significant insider selling has been recorded for ARYX in the recent period.
Is ARYx Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARYX is bullish with an Insider Alignment Score of 74/100 and a net flow of $17.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ARYX Frequently Asked Questions
Understanding ARYX Insider Activity
Insider trading at ARYx Therapeutics, Inc. (ARYX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading ARYX stock, having executed 46 transactions in the past 90 days. The most active insider is Advisors Llc Orbimed (Executive), who has made 1 transactions totaling $8.0M.
Related Tools
Track ARYx Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ARYX file new Form 4 transactions